Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Hanjiang Pharmaceutical Group is a China-based pharmaceutical manufacturer focused primarily on active pharmaceutical ingredients, intermediates, and finished dosage forms. Founded in 1970 and headquartered in Hanzhong, Shaanxi, the company operates multiple cGMP-compliant API and intermediate plants and markets itself as a comprehensive pharmaceutical group. Hanjiang has particular strength in small-molecule APIs, including human and veterinary products, and is described as a major domestic base for anthelmintic API manufacturing and export. The company also offers commercial manufacturing and CMO services for APIs, intermediates, and finished dosage forms. Its business appears centered on manufacturing, quality/regulatory compliance, and global export rather than a novel clinical-stage proprietary biotech pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hanjiang.